Compare Charles River Laboratories Intl. Inc (CRL) vs Firy Inc. (FIRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Firy Inc. — how do they compare? Charles River Laboratories Intl. Inc trades at $228.88 (market cap $11.14B), while Firy Inc. trades at $8.5 (market cap $125.48M). The key difference: Charles River Laboratories Intl. Inc is far larger — about 88.8× Firy Inc.'s market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Firy Inc. nearer its low. Which is the better fit depends on your goals.
| CRL | FIRY | |
|---|---|---|
Market Cap | $11.14B | $125.48M |
Sector | Health | Consumer Cyclical |
52-Week High | $233.60 | $12.45 |
52-Week Low | $145.57 | $2.28 |
Enterprise Value | $14.00B | $69.16M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
FIRY trades at $8.44, down 1.17% on the day, with a bullish technical signal from moving averages despite recent price weakness. The company reported Q1 2026 revenue growth but continues to post significant losses, with a net income margin of -57.48%. Recent developments include a corporate rebrand from Skillz Inc. and a major legal victory, though cash flow remains negative.
The outlook remains challenging due to persistent unprofitability and negative cash flows, offset by potential from the rebrand and legal win. Risks include high burn rate and competitive pressures. Analyst sentiment is mixed with a hold-dominated consensus, suggesting cautious optimism pending sustained operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →
